Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: A 12-month follow-up study

American Heart Journal

Volumn 158, Issue 3, 2009, Pages 444-450

  Paraskevaidis, Ioannis A ^a   Farmakis, Dimitrios ^a   Papadopoulos, Costantinos ^a   Ikonomidis, Ignatios ^a   Parissis, John ^a   Rigopoulos, Aggelos ^a   Iliodromitis, Efstathios K ^a   Kremastinos, Dimitrios Th ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; VERAPAMIL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; SYSTOLE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; SYSTOLE;

EID: 68849084060     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.06.013     Document Type: Article

References (33)

1. Maron B.J., Spirito P., Green K.J., et al. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 10 (1987) 733-742
2. Maron B.J. Hypertrophic cardiomyopathy. A systematic review. JAMA 287 (2002) 1308-1320
3. Elliott P., and McKenna W.J. Hypertrophic cardiomyopathy. Lancet 363 (2004) 1881-1891
4. Maron M., Olivotto I., Zenovich A.G., et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114 (2006) 2232-2239
5. Maron B.J., Robert W.C., and Epstein S.E. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 65 (1982) 1388-1394
6. Nagueh S.F., Bachinski L.L., Meyer D., et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104 (2001) 128-130
7. Yang H., Sun J.P., Lever H.M., et al. Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 16 (2003) 233-239
8. Kato T.S., Noda A., Izawa H., et al. Discrimination of nonobstructive cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation 110 (2004) 3808-3814
9. Kaluzynski K., Chen X., Emelianov S.Y., et al. Strain rate imaging using two-dimensional speckle tracking. IEEE Trans Ultrason Ferroelectr Freq control 48 (2001) 1111-1123
10. Leitman M., Lysyansky P., Sidenko S., et al. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17 (2004) 1021-1029
11. Serri K., Reant P., Lafitte M., et al. Global and regional myocardial function quantification by two-dimensional strain; application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1175-1181
12. Bauer F., Shiota T., White R.D., et al. Determinant of left atrial dilation in patients with hypertrophic cardiomyopathy; a real-time 3-dimensional echocardiographic study. J Am Soc Echocardiogr 17 (2004) 968-975
13. Tsang T.S., Barnes M.E., Gersh B.J., et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90 (2002) 1284-1289
14. Matsumura Y., Elliott P.M., Virdee M.S., et al. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy; relation to symptoms and exercise capacity. Heart 87 (2002) 247-251
15. McMahon C.J., Nagueh S.F., Pignatelli R.H., et al. Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation 109 (2004) 1756-1762
16. Sachdev V., Shizukuda Y., Brenneman C.L., et al. Left atrial volumetric remodeling is predictive of functional capacity in non-obstructive hypertrophic cardiomyopathy. Am Heart 149 (2005) 730-736
17. Losi M.A., Betocchi S., Aversa M., et al. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol 94 (2004) 895-900
18. Paraskevaidis I.A., Adamopoulos S., and Kremastinos D.T. Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study. J Am Coll Cardiol 37 (2001) 1685-1691
19. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
20. Klues H.G., Shiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
21. Vahanian A., Baumgartner H., Bax J., et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28 (2007) 230-268
22. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
23. Panza J.A., Petrone R.K., Fananapazir L., et al. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 19 (1992) 91-99
24. Paraskevaidis I.A., Panou F., Papadopoulos C., et al. Evaluation of left atrial longitudinal function in patients with hypertrophic cardiomyopathy: a tissue Doppler imaging and two-dimensional strain study. Heart 95 (2009) 483-489
25. D'Andrea A., Caso P., Romano S., et al. Association between left atrial myocardial function and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study. Int J Cardiol 132 (2009) 354-363
26. Olivotto I., Cecchi F., Casey S.A., et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104 (2001) 2517-2524
27. Maron B.J., Olivotto I., Bellone P., et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 39 (2002) 301-307
28. Wigle E.D., Rakowski H., Kimball B.P., et al. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92 (1995) 1680-1692
29. Spirito P., Seidman C.E., McKenna W.J., et al. Management of hypertrophic cardiomyopathy. N Engl J Med 30 (1997) 775-785
30. Lossi M.A., Betocchi S., and Grimaldi M. Heterogeneity of left ventricular filling dynamics in hypertrophic cardiomyopathy. Am J Cardiol 73 (1983) 987-990
31. Bonow R.O., Frederick T.M., Bacharach S.L., et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306 (1982) 1018-1022
32. Yu E.H., Omran A.S., Wigle E.D., et al. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 36 (2000) 2219-2225
33. Gruver E.J., Fatkin D., Dodds G.A., et al. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. Am J Cardiol 83 (1999) 13H-18H